Capilliposide from Lysimachia capillipes promotes terminal differentiations and reverses paclitaxel resistance in A2780T cells of human ovarian cancer by regulating Fos/Jun pathway
10.1016/j.chmed.2021.09.009
- Author:
Ke ZHANG
1
;
Ruping ZHAO
1
;
Yuanyuan CHEN
1
;
Qinghua DENG
1
;
Hanyue YING
2
Author Information
1. Center for Radiation Oncology, Affiliated Hangzhou Cancer Hospital, Zhejiang University School of Medicine
2. The Forth Clinical Medical College, Zhejiang Chinese Medical University
- Publication Type:Journal Article
- Keywords:
cancer stem cell;
capilliposide;
chemo-resistance;
Fos gene;
Lysimachia capillipes hemsl;
ovarian cancer
- From:
Chinese Herbal Medicines
2022;14(1):111-116
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the potential effect of Lysimachia capillipes capilliposide (LCC) on the chemo sensitivity and the stemness of human ovarian cancer cells. Methods: Cell Counting Kit-8 (CCK8) was used to measure the IC
